Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-08

Clinical Trial Update: A Study on the Efficacy and Safety of Venetoclax Combined With HAA Regimen in Newly Diagnosed Young AML. [Phase 1, Phase 2]

View source ↗

Summary

Early-stage study assessing the efficacy and safety of venetoclax in combination with the HAA regimen for newly diagnosed young patients with acute myeloid leuk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venetoclax (venetoclax)

Snippet

Sponsor: ZePing Zhou | Conditions: Acute Myeloid Leukemia, Venetoclax | Phase 1, Phase 2 | Status: UNKNOWN